PrP、14-3-3蛋白检测与海洛因海绵状白质脑病可传播性研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
背景与目的
     海洛因海绵状白质脑病(Heroin Spongiform Leukoencephalopathy,
    HSLE)是一种与经鼻烫吸海洛因有关的,主要表现为走路不稳、言语不
    清等小脑受损症状,主要累及脑白质的神经系统疾病。1982年由Wolters
    等在荷兰首次发现,以后德国、意大利、比利时和美国等地陆续有
    个案报道。除1982年荷兰和我们2000年8月报道成批发生外,其它均
    为个案报道。HSLE的临床表现与急、慢性海洛因中毒完全不同,主要
    表现为小脑性共济失调。HSLE的发病机理不明。其脑部病理改变为脑
    白质的广泛空泡伏变性,与可传播性海绵状脑病(Transmissible
    Spongiform Encephalopathy,TSE)的病理改变相似。TSE的诊断金标准
    是脑组织免疫组化PrP阳性,近年来发现脑脊液(CSF)14-3-3蛋白检
    测在诊断Creutzfeldt-Jacob病(CJD)方面的敏感性和特异性都很高,被
    认为是CJD的可靠生前诊断指标。为明确HSLE与TSE的关系,我们对
    收集到的29例HSLE患者进行血液和CSF检查、头颅影像学和脑组织
    病理、免疫组化研究,患者脑组织匀浆鼠脑内接种传递实验研究。
     材料与方法
     所有病例均为我科自2000年3月以来收治的HSLE患者,一共29
    例。所有病例进行脑电图、头颅影像学检查,3例尸检,11例脑组织活
    检,HE、刚果红、髓鞘染色及GFAP、PrP免疫组化。采集患者血液和CSF,
    进行CSF常规及细胞学、糖、蛋白质和氯化物;血液和CSF病毒学、弓
    形体、梅毒检测;CSF 14-3-3蛋白Western Blot检测。2例死亡患者脑
    组织匀浆进行Wistar大鼠脑内接种,观察期6个月。
     结 果
     所有患者HIV、HSV、MCV、EB、梅毒螺旋体、弓形体抗体检查均
    为阴性,无合并感染者CSF生化和常规检查正常。CSF14-3-3蛋白
    
    做stern Blot检坝均为阴性。
     CT显示病变部位白质内界限清楚的对称低密度病灶,无水肿及占位
    效应。Mill示病变部位臼质广泛异常信号,呈长 TI长 TZ改变,FI。AIR
    序列成象显示白质高信号改变,病变范围基本同TZ加权像所见一致,增
    强无强化。
     病理结果显示灰质神经细胞无明显减少,灰质无空泡形成。从灰白
    质交界处向白质空泡逐渐增多,白质区大量大小小均空泡形成,脑肉质
    呈海绵状改变。小血管周围无明显空泡改变,亦无水肿及炎性细胞浸炯。
    胶质增生不明显,少突胶质细胞相对少。未见缺血坏死病灶。PrP免疫组
    化可见神经元阳性反应。电镜:少突胶质细胞大量空泡退行性变,线粒
    体肿胀,内质网扩张,髓鞘有空泡,很多部位髓鞘被涡轮状空泡裂解。
     脑内接种大鼠6个月内没有发病,脑组织病理检查无异常发现。
     结论
     1.HSLE是一种与经鼻烫吸海洛因有关的,主要表现为小脑受损症
    状,主要累及脑白质的系统性变性。
     2.HSLE病理改变;灰质正常,白质海绵状空泡变性,电镜结果为
    少突胶质细胞大量空泡退行性变,线粒体肿胀,内质网扩张,髓鞘有空
    泡,很多部位髓鞘被涡轮状空泡裂解。
     3.HSLE的CT表现为白质内界限清楚的对称低密度病灶,NlEl显
    示为界限清楚的长H长TZ病灶,FLAIR序列成象显示白质高信号改变,
    病变范围基本同TZ加权像所见一致,增强无强化。
     4.HSLE与常见病毒、梅毒螺旋体、弓形体感染无关。
     5.HSLE不是可传播性海绵状脑病
Background and Purpose
     Heroin Spongiform Leukoencephalopathy(HSLE) is a neurological
     disorder mainly affected brain white matter,which is related with inhalation
     of the pyrolysate of heroin.HSLE was firstly discovered in Netherlands in
     1982. Since then, individual cases were reported in German, Italy, Belgium,
     the United States and Taiwan,except for the report of mass occurrence in the
     Netherlands( 1982) by Wolters and in the Chinese mainland by us(2000).The
     etiology and pathogenesis of HSLE are unknown.Clinical features of HSLE
     were different from acute or chronic heroin toxication absolutely. The main
     symptom of HSLE is cerebellar ataxia.The main pathological feature of
     lISLE was extensive vacuolation in white matter,which was like that of
     transmissible spongiform encephalopathy(T SE). The golden diagnostic
     standard of TSE is positive PrP immunohistochemistry reaction iii brain
     tissue.Recently, 14-3-3 protein in CSF was found to have high sensibility and
     specificity in CJD patients,and was regarded as a reliable premortem
     diagnostic standard of CJD.To make clear the relationship between HSLE
     and TSE,laboratory examination of blood and CSF, neurological
     imaging,brain tissue pathological and immunohistochemistry research were
     carried out in all the 29 cases of HSLE we collected and inoculation of
     homogenate of dead patientsrain to ratsrain to observed the
     transmisibility of HSLE were conducted.
    
     Materials and Methods
     The sum of cases of HSLE is 29.EEG,CT,MRI were carried out for each
     patient.Brain biopsy was conducted in 11 cases ,and necropsy was conducted
     in 3 dead cases.HE.,Congo red,myelin stains and GEAP,PrP
     immunohistochemistry stains were carried out.Blood and CSF of patients
     were collected for syphilis,toxoplasma gondii and routine,cytological,
     glycose,protein,chloride, virology examination and 14-3-3 protein Western
     Blot of CSF were were carried out too.Homogenate of 2 dead patients抌rain
     was inoculated in Wistar ratsrain,and the observation period was 6 months.
    
    
    
    
    
    
     Results
     I-LIVHSV,MCV,EB,toxoplasma gondii,syphilis examination were all
     negative.Routine and biochemistry examination of CSF were normal without
     infection.Immunoassay detection of 14-3-3 protein in CSF were negative.
     CT showed Symmetric low-density lesions with distinct boundaries in
     white matters,without effect of edema or mass.MRI showed extensive
     abnormal signals in white matters in lesion location with long TI and long
     T2.FLAJR images showed higher signals in white matters of lesion locations
     and their ranges mainly according with T2 images.
     The pathology character was spongiform vacuolar degeneration of white
     matter and neurons in grey matter did not decreased.There were no
     vacuole,edema and lymphoid infiltration in grey matter and small vessel
     periphery.There were no apparent reactive astroglial proliferation.
     o ligodendroglia relatively decreased. Positive reactivities of prion protein by
     immunohistochemistry were seen in neurons.Foci od ischemic necrosis were
     not found.Electron microscopy revealed a multivacuolar degeneration of the
     oligodendroglias. Swollen mitochondria and distended endoplasmic reticulum
     were found in the remaining cytoplasm.Ln many myelin sheaths vacuoles
     formed between the myelin lamellae by splitting of the intraperiod lines were
     observed.In some places continuity of the myelin sheath was interrupted by a
     ball of whorled myelin layer.
     The inoculated rats did not onset in 6 months,and the
引文
1. Wolters EC,van Wijngaarden GK,Stam FC,et al.Leucoencephalopathy after inhaling "heroin" pyrolysate.Lancet, 1982,2(8310) : 1233-1237
    2. Chang YJ,Tsai CH,Chen CJ.Leukoencephalopathy after inhalation of heroin vapor. J Formos Med Assoc,1997,96(9) :758-760
    3. Celius EG,Andersson S.Leucoencephalopathy after inhalation of heroin:a case report.J Neurol Neurosurg Psychiatry, 1996,60(6) :694-695
    4. Hedley Whyte ET.Leukoencephalopathy and raised brain lactate from heroin vapor inhalation.Neurology,2000,54(10) :2027-2028
    5. Kriegstein AR,Shungu DC,Millar WS,et al.Leukoencephalopathy and raised brain lactate from heroin vapor inhalation.Neurology, 1999,53(8) : 1765-1773
    6. Weber W,Henkes H,Moller P,et al.Toxic spongiform leucoencephalopathy after inhaling heroin vapour.Eur Radiol, 1998,8(5) :749-755
    7. Nuytten D,Wyffels E,Michiels K,et al.Drug-induced spongiform leucoencephalopathy, a case report with review of the literature. Acta Neurol Belg,1998,98(1) :32-35
    8. Rizzuto N,Morbin M,Ferrari-S,et al.Delayed spongiform leukoencephalopathy after heroin abuse.Acta Neuropathol, 1997,94(1) :87-90
    9. Tan TP,Algra PR,Valk J.Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings.AJNR Am J Neuroradiol, 1994,15(1) : 175-178
    10. Sempere AP,Posada I,Ramo C,et al.Spongiform leucoencephalopathy after inhaling heroin.Lancet,1991,338(8762) :320
    11. Hungerbuhler H,Waespe W. Leukoencephalopathy following inhalation of heroin pyrolysate.Schweiz Med Wochenschr. 1990,120(48) : 1801-1805
    12. Roulet Perez-E.Maeder P,Rivier L,et al.Toxic leucoencephalopathy after heroin ingestion in a 21/2-year-old child.Lancet, 1992,340(8821) : 729
    13. Kumar R,West DM,Jingree M,et al.Unusual consequences of heroin overdose:Rhabdomyolysis,acute renal failure,paraplegia and hypercalcaemia. Br J Anaesth,1999,83(3) :496-498
    14. Babic GD,Jovic-Stosic JV,Jankovic-Mladenovska SR,et al.Acute respiratory distress syndrome:Complication of acute intoxication.Toxicol Lett,2000,116(Supp1. 1) :83
    15. Rice EK,Isbel NM,Becker GJ,et al.Heroin overdose and myoglobinuric acute renal failure.Clin Nephrol, 2000,54(6) :449-454
    
    
    16. Kovacs GL,Sarnyai Z,Szabo G.Oxytocin and addiction:a review. Psychoneuroendocrinology.l998,23(8) :945-962
    17. Chalela JA,Wolf R,Kasner SE.MRI identification of early white matter injury in hypoxic-ischemic encephalopathy.Neurology,2000,54(7Supp.3) : A449
    18. Diez-Tejedor E,Frank A,Gutierrez M,et al.Encephalopathy and biopsy-proven cerebrovascular inflammatory changes in a cocaine abuser.Eur JNeuro.l998,5(1) :103-107
    19. Filley CM.Toxic leukoencephalopathy.Clin Neuropharmacol, 1999,22(5) : 249-260
    20. Prusiner SB .Novel proteinaceous infectious particles cause scrapie. Science,1982,21(2) : 136-144
    21. Basier K,Oesch B,Scoff M,et al.Scrapie and cellular PrP isoform are encoded by the same chromosomal gene.Cell,1986,46(3) :417-428
    22. Hope J,Morton LJO.Farquhar CS,et al.The major poly-peptide of scrapie-associated fibrils(SAF) has the same size,charge distribution and N-terminal protein sequence as predicted for the normal brain protein(PrP).EMBOJ,1986,5(10) :2591-2597
    23. Bueler HR,Fischer M,Lang Y,et al.Nornal development and behaviour of mice lacking the neuronal cell-surface PrP protein.Nature,1992,356(6370) : 577-582
    24. Pan KM,Baldwin M,Ngulgen J,et al.Conversion of α-helic into β-sheets features in the formation of the scrapie prion proteins.Proc Natl Acad Sci USA,1993,90(23) :10962-10966
    25. Huang Z,Gabriel JM,Baldwin MA,et al.proposed three-dimensional structure for the cellular prion protein.Proc Natl Acad Sci US A, 1994,91 (15) : 7139-7143
    26. Meyer RK,McKinley MP,Bowman KA,et al. Separation and properties of cellular and scrapie prion proteins.Proc Natl Acad Sci USA, 1986,83(8) :2310-2314
    27. Oesch B.Westaway D.Walchli M,et al.A cellular gene encodes scrapie PrP 27-30 proteiaCell, 1985,40(4) :735-746
    28. Taraboulos A,Serban D, Prusiner SB.Scrapie prion protein accumulate in the cytoplasm of persistently infected cultured cells.J Cell Biol,1990, 110(6) :2117-2132
    
    
    29. Vey M,Pilkuhn S,Wille H,et al.Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.Prdc Natl Acad Sci USA,1996,93(25) :14945-14949
    30. Horwich AL,Weissman JS.Deadly conformations-protein misfolding in prion disease.Cell, 1997,89(4) :499-510
    31. Brown DR,Schmidt B,Kretzschmar HA.Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.Nature, 1996,3 80(6572) : 345-347
    32. Kuwahara C,Takeuchi AM,Nishimura T,et al.Prion prevent neuronal cell-line death.Nature, 1999,400(6741) :225-226
    33. Will RG,Ironside JW,Zeidler M,et al.A new variant of Creutzfeldt-Jacob disease in the UK.Lancet,1996,347(9006) :921-025
    34. McCardle L.Human prion diseases.Bri J Biomed Sci,1997,54(1) :2-4
    35. Takamiya K,Iwasaki Y,Kinoshita M.MRI in Creutzfeldt-Jacob disease. Neurology,1996,47(2) :611
    36. DeArmond SJ,Prusier SB.Etiology and pathogenesis of prion diseases. Am J Pathol,1995,146(4) :785-811
    37. Weber T,Aguzzi A.The spectrum of transmissible spongiform encephalopathies. Intervirology, 1997,40(2-3) : 198-212
    38. Kitamoto T,Doh-ura K,Muramoto T,et al.The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.Am J Pathol.l 992,141(2) :271-277
    39. Castellani R,Parchi P,Stahl J,et al.Early pathologic and biochemical changes in the Creutzfeldt-Jacob disease: study of brain biopsies.Neurology, 1996,46(6) : 1690-1693
    40. Oberdieck U,Xi YG,Pocchiari M,et al.Characterisation of antisera raised against species-apecific peptide sequences from scrapie-associated fibril protein and their application for post-mortem immunodiagnosis of spongiform encephalopathies.Arch Virol,1994,136(1-2) :99-110
    41. Kascsak RJ,Rubenstein R,Merz PA,et al.Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.J virol,1987, 61(12) :3688-3693
    42. O'rourke KI,Baszler TV,Miller JM,et al.Monoclonal antibody F89/160. 1. 5 defines a conserved epitope on the ruminant prion protein.J Clin Microbio, 1998,36(6) : 1750-1755
    
    
    43. Ichimura T,Isobe T,Okuyama T,et al.Molecular clonig of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependnt activator of tyrosine and tryptophan hydroxylases.Proc Natl Acad Sci USA, 1988, 85(19) :7084-7088
    44. Boston PF, Jackson P.Thompson RJ.Human 14-3-3 protein: radioimmunoassay,tissue distribution,and cerebrospinal fluid levels in patients with neurological disorders.J neurochem, 1982,38(5) : 1475-1482
    45. Hsich G, Kenney K, Gibbs CJ Jr,et al.The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathy. N Engl J Med,1996,335(13) :924-930
    46. Zerr I, Bodemer M, Gefeller 0, et al.Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol,1998,43(1) :32-40
    47. Lemstra AW, van Meegen MT, Vreyling JP,et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease:a prospective study in 112 patients. Neurology, 2000,55(4) : 514-516
    48. Dorner C,Ullrich A,Haring HU,et al.The kinesin-like motor protein KIF1C occurs in intact cells as a dimer and associates with proteins of the 14-3-3 family.J Biol Chem,1999,274(47) :33654-33660
    49. Finnie C,Borch J,Collinge DB. 14-3-3 proteins:eukaryotic regulatory proteins with many functions.Plant Mol Biol,1999,40(4) :545-554
    50. Muramoto T.Kitamoto T,Tateishi J,et al. Successful transmission of Creutzfeldt-Jacod disease from human to mouse verified by prion protein accumulation in mouse brains.Bram Research, 1992,599(2) :309-316
    51. Brown P,Gibbs CJ Jr,Rodgers-Johnson P,et al.Human spongiform encephalopathy:the national institutes of health series of 300 cases of experimentally transmitted disease.Ann Neurol,1994,35(5) :513-529
    52. Tateishi J,Doi H,Sato Y,et al.Experimental transmission of human subacute spongiform encephalopathy to small rodents.III.Further transmission from three patients and distribution patterns of lesions in mice.Acta Neuropathol,1981,53(2) : 161-163
    53. Strang J.Gurling H.Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts.Br J Addict, 1989,84(9) : 1011-1019
    54. Celius EG.Andersson S.Leucoencephalopathy after inhalation of heroin:
    
    a case report. J Neurol Neurosurg Psychiatry, 1996,60(6):694-695
    55. Kimmel DW,Wijdicks EF,Rodriguez M.Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology, 1995,45(2):374-376
    56. Lucia P,Pocek M,Passacantando A, et al. Multifocal leukoencephalopathy induced by levamisole. Lancet, 1996,348(9039): 1450
    57. Chen TC, Hinton DR, Leichman L,et al. Multifocal inflammatory leukoencephalopathy associated with levamisole and 5-fluorouracil:case report. Neurosurgery, 1994,35 (6): 1138-1142
    58. Lucchinetti CF,Kimmel DW, Pavelko K, et al.5-fluorourcil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus. Exp Neurol, 1997,147(1): 123-129
    59. Hofman FM,Hinton DR, Johnson K, et al. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med, 1989,170(2):607-612
    60. Patel AG, Rao R. Transient Ara-c leukoencephalopathy:MR findings. J Comput Assist Tomogr, 1996,20(1): 161-162
    61. Martinez AJ, Boehm R, Hadfield MG. Acute hexachorophene encephalopathy: clinico-neuropathological correlation. Acta Neuropathol, 1974, 28(2):93-103
    62. Gottfried JA, Meyer SA, Shungu DC, et al. Delayed posthypoxic demyelination. Association with arysulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology, 1997,49(5): 1400-1404
    63.史玉泉.实用神经病学.第二版.上海:上海科学技术出版社,1994.402-404
    64. Allan B,Tuft S.Transmission of Creutzfeldt-Jacob disease in corneal grafts. BMJ, 1997,315 (7122): 1553-1554
    65. Huillard d'Aignaux J, Alperovitch A, Maccario J.A statistical model to identify the contaminated lots implicated in iatrogenic transmission of Creutzfeldt-Jacob disease among French human growth homone recipients. Am J Epidemiol, 1998,147(6):597-604
    66. Hernandez Palazon J,Martinez Lage JF, Tortosa JA, et al. Anaesthetic management in patient suspected of, or at a risk of, having Creutzfeldt-Jacob disease. Br J Anaesth, 1998,80(4):516-518
    67.王得新.神经病毒学-基础与临床.北京:人民卫生出版社,2000,416-515